IP Library Granted Patent US 10,517,882
Granted Patent B2
US 10,517,882 · App. 15/816,850 · Granted Dec 31, 2019

Method for healing of an infected acne lesion without scarring

Inventors: Dov Tamarkin (Maccabim, IL); Elana Gazal (Rehovot, IL); Rita Keynan (Rehovot, IL); Meir Eini (Ness Ziona, IL); David Schuz (Gimzu, IL)
Assignee: Foamix Pharmaceuticals Ltd.
A61K31/65A61K9/0014A61K9/06A61K9/122A61K47/06A61K47/10A61K47/12A61K47/24A61K47/44
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,517,882
App. No.
15/816,850
Granted
Dec 31, 2019
Kind
B2
Abstract

Methods of treatment and dosage regimes using hydrophobic gel or foam compositions comprising a tetracycline antibiotic for accelorating the return of skin integrity and or in treating or alleviating a disorder including impetigo, acne, rosacea, a skin disease caused by a bacteria or a tetracycline antibiotic responsive disease, wherein the foam composition or gel is administered topically to a target area on a subject having the disorder and wherein the target area comprises an area of skin, or mucosa or an eye.

Claims (14)

1. A method for healing of an infected acne lesion without scarring, comprising topically administering at least once daily an effective amount of a minocycline antibiotic foam to an infected acne lesion, wherein the minocycline antibiotic foam is produced from a foamable composition upon addition of a liquefied or compressed gas propellant, the foamable composition comprising:

(a) 60% to 90% by weight of one or more hydrophobic oils selected from the group consisting of a mineral oil, a soybean oil, a coconut oil, cyclomethicone, and a mixture of two or more thereof;

(b) a wax selected from the group consisting of a beeswax, a hydrogenated castor oil, and a mixture thereof;

(c) at least one solid fatty alcohol having a carbon chain length of 14 to 22 carbons;

(d) at least one solid fatty acid having a carbon chain length of 12 to 28 carbons; and

(e) 0.2% to 10% by weight of a minocycline; and

wherein the foamable composition does not comprise a surfactant.

2. The method of claim 1 , wherein the minocycline is present in a free base form, a salt form, a hydrate form, or a complex form.

3. The method of claim 1 , wherein the minocycline is 1 to 4% by weight of the foamable composition.

4. The method of claim 1 , wherein the at least one solid fatty alcohol is selected from the group consisting of myristyl alcohol, cetostearyl alcohol, stearyl alcohol, behenyl alcohol, and a mixture of two or more thereof.

5. The method of claim 1 , wherein the least one solid fatty acid having a carbon chain length of 12 to 28 carbons comprises stearic acid.

6. The method of claim 1 , wherein the foamable composition further comprises fumed silica.

7. The method of claim 1 , wherein the minocycline is micronized.

8. The method of claim 1 , wherein the foamable composition further comprises an additional active agent.

Assignments (11)
SECURITY INTEREST Recorded Dec 28, 2023
From: JOURNEY MEDICAL CORPORATION; JG PHARMA, INC.
To: SWK FUNDING LLC
Reel/Frame 066157/0079 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2022
From: VYNE THERAPEUTICS INC.; VYNE PHARMACEUTICALS INC.
To: JOURNEY MEDICAL CORPORATION
Reel/Frame 058925/0568 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 22, 2021
From: VYNE THERAPEUTICS INC.
To: VYNE PHARMACEUTICALS INC.
Reel/Frame 058463/0208 →
RELEASE OF SECURITY INTEREST Recorded Sep 20, 2021
From: PERCEPTIVE CREDIT HOLDINGS II, LP
To: VYNE PHARMACEUTICALS LTD. (F/K/A FOAMIX PHARMACEUTICALS LTD.)
Reel/Frame 057544/0138 →
RELEASE OF SECURITY INTEREST Recorded Sep 20, 2021
From: PERCEPTIVE CREDIT HOLDINGS II, LP
To: VYNE THERAPEUTICS INC. (F/K/A MENLO THERAPEUTICS INC. AND SUCCESSOR-IN-INTEREST TO VYNE PHARMACEUTICALS LTD., F/K/A FOAMIX PHARMACEUTICALS LTD.)
Reel/Frame 057544/0708 →
PATENT SECURITY AGREEMENT Recorded Feb 17, 2021
From: VYNE THERAPEUTICS INC.
To: PERCEPTIVE CREDIT HOLDINGS II, LP
Reel/Frame 055326/0009 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 4, 2021
From: VYNE PHARMACEUTICALS LTD.
To: VYNE THERAPEUTICS INC.
Reel/Frame 055215/0298 →
CHANGE OF NAME Recorded Nov 4, 2020
From: FOAMIX PHARMACEUTICALS LTD.
To: VYNE PHARMACEUTICALS LTD.
Reel/Frame 054306/0387 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 18, 2019
From: TAMARKIN, DOV; GAZAL, ELANA; KEYNAN, RITA; EINI, MEIR; SCHUZ, DAVID
To: FOAMIX LTD.
Reel/Frame 050757/0874 →
CHANGE OF NAME Recorded Oct 18, 2019
From: FOAMIX LTD.
To: FOAMIX PHARMACEUTICALS, LTD.
Reel/Frame 050767/0415 →
PATENT SECURITY AGREEMENT Recorded Jul 30, 2019
From: FOAMIX PHARMACEUTICALS LTD
To: PERCEPTIVE CREDIT HOLDINGS II, LP
Reel/Frame 049912/0045 →
Cited By (1)
US 12,661,407